Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

FRM F013 - Protecting America's Youth: Responding to Tanning Industry Arguments & Advancing Effective Policies

Open admission to eligible categories, no tuition or ticket


Date: Saturday, August 03

CME Credits: 2.00

Location: Sutton South

Time: 10:00 AM - 12:00 PM

Director: Bruce A. Brod, MD, FAAD - Handout


  • Craig N. Burkhart, MD, FAAD - Handout
  • Lawrence J. Green, MD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Discuss the latest scientific evidence linking use of indoor tanning devices to the development of non-melanoma skin cancers and melanoma and recognize gaps in our knowledge on the subject.
  • Predict and respond to argument made by the tanning industry to further their own agenda.
  • Develop strategies to implement and/or engage in effective advocacy campaigns at the state and federal level to improve regulation of the indoor tanning industry.

The American Academy of Dermatology Association in collaboration with Academy members, state dermatology societies and others have been advocating for the advancement of effective policies at the state and federal level to more strictly regulate the indoor tanning industry, particularly with regard to prohibiting minors from using indoor tanning beds, for several years. In 2011, California became the first state in the U.S. to prohibit all teens and young adults under the age of 18 from using tanning beds. In 2010, the U.S. Food and Drug Administration held a hearing on reclassification of indoor tanning devices and draft regulations are expected to be released in 2012. Over the past several years, the tanning industry’s arguments against increased regulation have become more aggressive in attacking the large body of scientific evidence which confirms use of indoor tanning beds significantly increases one’s risk of developing non-melanoma skin cancers and melanoma. In order to continue to advance effective policies, dermatologists and other advocates must be prepared to respond to the industry’s arguments in front of policymakers, anticipate questions, and address different political ideologies and audiences in appropriate ways.